Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab Plus Cyclophosphamide Followed by Belimumab for Lupus Nephritis
NCT02260934Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jul 2015
- Primary completion
- Mar 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of belimumab in lupus nephritis (LN), sponsored by National Institute of Allergy and Infectious Diseases. Started Jul 2015; status: completed.
02
Drugs
belimumab
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT02260934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02260934.